News for Anatara Lifesciences Limited (ANR.AX)

Published at

Dec 4, 2024 3:26 AM

by themarketherald.com.au

positive

positive

Anatara reaches required level for recruitment in trial for IBS treament

Anatara Life Sciences Ltd has successfully enrolled 60 people in its Stage 2 trial to test its Gastrointestinal ReProgramming (GaRP) treatment

ANR.AX

Read more →
Published at

Jul 30, 2024 6:18 AM

by smallcaps.com.au

neutral

neutral

Anatara Lifesciences on track with recruitment for Stage 2 of GaRP IBS trial

Anatara Lifesciences (ASX: ANR) has reported that recruitment for Stage 2 of its pivotal GaRP (Gastrointestinal ReProgramming) trial for the treatment of

ANR.AX

Read more →
Published at

Jun 13, 2024 3:10 AM

by smallcaps.com.au

neutral

neutral

Anatara Lifesciences’ Stage 2 GaRP trial for IBS treatment gains momentum

Recruitment is advancing for Stage 2 of Anatara Lifesciences' (ASX: ANR) pivotal gastrointestinal reprogramming (GaRP) trial to treat irritable bowel

ANR.AX

Read more →
Published at

Jun 11, 2024 1:20 AM

by smallcaps.com.au

negative

negative

Anatara Lifesciences embarks on Stage 2 of GaRP trial for treatment of irritable bowel syndrome

Anatara Lifesciences (ASX: ANR) has initiated Stage 2 of a Phase II gastrointestinal re-programming (GaRP) trial to treat patients with irritable bowel

ANR.AX

Read more →
Published at

Sep 29, 2023 4:53 PM

by marketscreener.com

mixed

mixed

Bionomics : Statutory Accounts - Form 6-K -September 29, 2023 at 10:53 am EDT

Statutory Accounts Director's Report In accordance with the Corporations Act 2001, the directors of...

REZ.AX PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE NINOY NINOF MGFRF MF6.DE LPCN CSN.MX CSGNE.SW CSGN.SW CSGKF CS CBIO BNOEF BNO.AX ADMS 7731.T 0I4P.L RPRX NBIX IDXX IDT.AX IDP.DE CYCN BIIBD.BA BIIBCL.SN BIIB.SN BIIB.MX BIIB.BA BIIB BHP.AX ANR.AX AND.AX 0K6R.L TEK.AX SVA.AX CAF.AX ACAD 1ST.AX 0A4W.L

Read more →
Published at

Mar 10, 2023 1:32 AM

by stockhead.com.au

negative

negative

ASX Health Stocks: Volpara jumps 10pc as US FDA makes new ruling on ‘dense breasts’ language

Volpara Health (ASX:VHT) rose 9% this morning after the US FDA finalised a new federal regulation on breast density language

ANR.AX

Read more →
Published at

Dec 22, 2022 3:01 PM

by stockhead.com.au

mixed

mixed

After a dismal year for ASX health stocks 2023 is showing signs of a recovery

The ASX health sector is down more than 8% as 2022 comes to end but in signs of optimism for 2023, Morgans has a basket of stocks to watch.

TD1.AX PME.AX NURPF NEU.AX NAN.AX MEM.AX KZIA KZA.AX HXL.AX HHI.AX EX1.AX SCU.AX PIQ.AX OSL.AX MVF.AX EBO.NZ EBO.AX CSLN.MX CSLLY CSL.AX CMXHF BXPHF BOT.AX AVR.AX AMEUF AJJ.AX ADO.AX ZLDAF ZLD.AX WFL.AX VIP.AX VHT.AX UBI.AX SIG.AX REG.AX PNV.AX PBP.AX OVN.AX NTI.AX MEB.AX MDBIF LCT.AX CSX.AX CRON CPH.AX COPHF CAU.AX CALZF AT1.AX ARX.AX ANR.AX

Read more →
Published at

Oct 19, 2022 9:40 PM

by stockhead.com.au

mixed

mixed

Rise and Shine: What you need to know before the ASX opens

The ASX biotechs hitting their Phase III straps, Guy Le Page's graphite pick and why boring bonds are actually bonza

VRS.AX TGM.AX PFE.AX ODM.AX MPL.AX LPD.AX GED.AX FAU.AX DEL.AX CXL.AX CVV.AX CMD.AX CFO.AX CFFMF BUGLF BLG.AX AZS.AX AND.AX ADR.AX SI6.AX NVX.AX M8S.AX BWNAF BCB.AX ANR.AX ANL.AX AKN.AX WBE.AX TEK.AX SRK.AX SIH.AX PXXXF MP1.AX MGPPF GLV.AX

Read more →
Published at

Oct 19, 2022 9:15 AM

by themarketherald.com.au

neutral

neutral

Anatara Lifesciences (ASX:ANR) enters into mid-week trading halt

Anatara Lifesciences (ASX:ANR) has entered a trading halt while it plans a capital raise.

ANR.AX

Read more →
Published at

Oct 19, 2022 6:55 AM

by stockhead.com.au

mixed

mixed

LAST ORDERS: Today’s semi-serious look at some very serious ASX stuff

Time to unwind and catch up on some of the stuff you might have missed while Wednesday was happening right in front of you.

OPL.AX ODM.AX NVX.AX MPL.AX CXL.AX BCB.AX ANR.AX

Read more →